Zometa Study in Pediatric Acute Lymphoblastic Leukemia

PHASE3CompletedINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

January 31, 2014

Study Completion Date

August 31, 2015

Conditions
Osteoporosis
Interventions
DRUG

zolendronic acid

"patients will receive calcium \& vitamin D daily in addition to bisphosphonates (zolendronic acid ) every 3 months in the dose of~1. Initial dose: (0.025) mg /kg~2. Subsequent doses ( 0.05) mg /kg.~3. Maximum dose of 4 mg."

DRUG

calcium & vitamin D

patients will receive calcium \& vitamin D Dose of Calcium : 1500- 2000 gram elemental Calcium daily . Dose of Vitamin D ( calcitriol; one alpha) 800-1000 International Unit

Trial Locations (1)

11441

Children's Cancer Hospital Egypt 57357, Cairo

All Listed Sponsors
lead

Children's Cancer Hospital Egypt 57357

OTHER

NCT01656512 - Zometa Study in Pediatric Acute Lymphoblastic Leukemia | Biotech Hunter | Biotech Hunter